Introduction
============

Cardiovascular diseases are among the important global health problems and the most common causes of death worldwide, posing severe physical and economic losses not only to individuals but also to the entire community.[@b1-jir-11-265],[@b2-jir-11-265] Atherosclerosis is the leading cause of cardiovascular diseases, which causes hardening of the arterial wall, followed by a decrease in elasticity and a narrowing of the blood flow pathway and ultimately a decrease in the blood flow of the vital organs of the body, including the heart and brain.[@b3-jir-11-265]

Immune inflammation has now been known in the pathogenesis of atherosclerosis; inflammation is created with increasing oxidative stress, followed by events such as plaque rupture and, consequently, vascular arterial disorder.[@b3-jir-11-265] At the initial stage of atherosclerosis, cholesterol-rich lipoproteins are stored in the vessel wall and cause inflammatory responses in the surrounding cells; as a part of this vascular response, arterial endothelial cells express leukocytic adhesion molecules that leads to the attraction of circulating monocytes, their adherence to endothelium and differentiation into tissue macrophages.[@b4-jir-11-265]--[@b6-jir-11-265] These macrophages absorb lipids and create foam cells in blood vessels, with the first lesions being atherosclerotic processes, and play a very important role in the development and progress of atherosclerosis.[@b7-jir-11-265]

Nowadays, with the changing pattern of life along with the industrialization of societies and the changes in food habits and reduced physical activity, the incidence of cardiovascular disease, especially in developing countries, has been steadily increasing.[@b8-jir-11-265] Clinical and epidemiological evidence suggests a significant reduction in cardiovascular mortality among consumers of fruits, vegetables and materials extracted from plants due to the presence of polyphenolic compounds and their special flavonoids.[@b9-jir-11-265],[@b10-jir-11-265] Because of their antioxidant activity, flavonoids protect the destructive effects of reactive oxygen species, such as superoxide radicals.[@b11-jir-11-265] Owing to the role of flavonoids in the treatment of cardiovascular diseases, it is necessary to use plants that have beneficial effects for these diseases. One of such herbs is *Teucrium polium*.

*T. polium* from Teucrium class is an herbaceous, grassy, branchy, 10--35 cm height, white cotton plant, which is usually found in the Bayer, rocky and sandy beaches worldwide.[@b12-jir-11-265] In recent years, the antidiabetic, analgesic and antioxidant effects of this plant have been reported.[@b12-jir-11-265]--[@b15-jir-11-265] The use of *T*.*polium* in vitro reduces fatty acids. It is also used as peroxidation inhibitor of red blood cells.[@b16-jir-11-265]

Considering that cardiovascular diseases are among the most important causes of mortality, implementation of applicable research is necessary in order to recognize and reduce the risk factors of this disease. Meanwhile, investigation and identification of the effective factors on decreasing the level of inflammatory markers and lipid profiles is important for prevention and reduction of cardiovascular diseases. In this regard, due to the significant expansion of herbal medicine, it is essential to investigate and conduct research in this regard. Therefore, this study was conducted to investigate the effect of hydrolytic extract of *T*.*polium* on the level of some inflammatory and coagulant markers in hypercholesterolemic rats.

Materials and methods
=====================

Extract Preparation
-------------------

In this study, a condensed extract of *T*.*polium* was used, which was collected in spring from the Romshagan area in west Lorestan province and was dried and powdered by electric mill after identification and confirmation of scientific name. The 50 g of powder obtained was accurately weighed by a digital balance and was poured into an Erlenmeyer flask. Then, 320 mL of 96% ethanol and 80 mL of distilled water were added and incubated in a shaker incubator at 34°C and 140 rpm for 72 hours. The obtained solution was filtered with Whatman filter paper 1 in a rotary machine and ethanol was separated using the vacuum pump, so that solution was concentrated to one-third of the initial volume. Concentration of solution was then carried out for 5 days. The solution obtained from the last stage was sterilized in a flask and stored at 4°C.

Toxicity determination (LD~50~)
-------------------------------

Doses of 50, 100, 200, 400, 800 and 1600 mg/kg of *T*.*polium* hydroalcoholic extract (TPHAE) were selected and injected intraperitoneally into six groups of animals. The mortality rate was measured after 24 hours, while the LD~50~ was estimated using computer techniques. Then, 25 and 50% LD~50~ were selected as the doses to be used in this study (85 and 170 mg/kg body weight per day).

Grouping and treatment of animals
---------------------------------

For this experimental study, adult male Wistar rats with an average weight of 180 ± 20 g were used. Animals were purchased from the Animal Breeding Laboratory Center of Tehran Institute of Pasteur. Animals were stored in polycarbonate cages at 12 ± 2°C in 12 cycles of light and darkness and fed with special compressed food and water from Urban Plumbing. All the animals were placed under these conditions 1 week prior to the beginning of the study in order to adapt to the laboratory environment.

In order to implement this study, 24 adult male rats were randomly divided into four groups of six and orally administered food for 8 weeks. Group I (control) received only the daily diet in the 8 weeks.Group II (sham) received high-cholesterol diet (2%) in the 8 weeks.

To establish the same condition during experiments both experimental group 1 and 2 were treated with 2 cc solvent medication. Group III (experimental 1) received a high-cholesterol diet (2%) in the 8 weeks and a dose of 85 mg/kg of TPHAE from the fourth week.Group IV (experimental 2) received a high-cholesterol diet (2%) in the 8 weeks and a dose of 170 mg/kg of TPHAE from the fourth week.

For preparation of a high-cholesterol diet, cholesterol was procured from German Merck Company and the rats were given this highly concentrated cholesterol on daily basis at 2% of their body weight.

Measuring biochemical factors
-----------------------------

Animals were fasted for 12 hours prior to the beginning of the diet and after the completion of the study and then blood samples were collected from all rats twice, once at the beginning of the first week and again at the end of the eighth week. The collected blood samples were allowed to stand for 40 minutes at laboratory temperature to enable clotting and then centrifuged for serum separation at 2500 rpm for 10 minutes. After serum collection, the rate of inflammatory markers (IL-6, CRP, tumor necrosis factor-α \[TNF-α\] and fibrinogen) and lipid profiles (HDL, LDL, triglyceride \[TG\] and cholesterol) were measured for each rat by biochemical kits.

Total cholesterol, TG, LDL-cholesterol (LDL-c) and HDL-cholesterol (HDL-c) were measured using a biochemical enzyme kit and measured by Hitachi's Automatic Analyzer 902. ZellBio Kit (Ulm, Germany) was used to measure IL-6, CRP and Fibrinogen, and Diaclone kit (Besançon, France) and ELISA method were used for evaluation of GmbH and TNF-α.

Statistical analysis
--------------------

Statistical analysis was conducted using SPSS16 software (SPSS Inc., Chicago, IL, USA). The average level of variables for each group of rats was presented as mean ± standard error of mean. To compare the mean of quantitative variables before and after the intervention, paired samples *t*-test was used, and one-way analysis of variance and the Tukey's auxiliary tests were used (the true difference test, termed HSD) for comparing the mean of the groups. The significance level for all tests was considered as *P*\<0.05.

Ethical statement
-----------------

This study was carried out in accordance with the recommendations of International Council for Laboratory Animal Science. The protocol was approved by the Ethics Committee of Ilam University of Medical Sciences.

Results
=======

[Table 1](#t1-jir-11-265){ref-type="table"} shows the mean of inflammatory factors before and after study in control, sham and experimental 1 and 2 groups; however, as it can be seen, before the study, the mean of each inflammatory factor in all groups was approximately the same and there was no significant difference between the studied groups (*P*\>0.05).

Comparison of the mean inflammatory factors in each group before and after the intervention showed that at the end of the eighth week of study, the mean of each inflammatory factor in the control group receiving only the daily diet and also experimental group 2 (2% high-cholesterol diet and 170 mg/kg dose of TPHAE) did not change significantly (*P*\>0.05). While in the sham group receiving a high-cholesterol diet (2%), as well as experimental group 1 (2% high-cholesterol diet and 85 mg/kg dose of TPHAE), there was a significant increase in the mean of each inflammatory factor at the end of the eighth week of study ([Table 1](#t1-jir-11-265){ref-type="table"}).

The mean serum lipid profiles of control, sham and experimental 1 and 2 groups before and after the study are presented in [Table 2](#t2-jir-11-265){ref-type="table"}. The mean of lipid profiles before the study in all groups was approximately the same and no significant difference existed in this case (*P*\>0.05). As observed in [Table 2](#t2-jir-11-265){ref-type="table"}, the mean serum levels of TG, cholesterol and LDL-c in the sham group receiving cholesterol diet (2%), as well as experimental group 1 (2% high-cholesterol diet and 85 mg/kg dose of TPHAE) significantly increased from the start to the end of study (sham group: TG: *P*\<0.01, cholesterol and LDL-c: *P*\<0.001; experimental group 1: TG: *P*\<0.001, cholesterol and LDL-c: *P*\<0.01). However, there was no significant change in the serum levels of these three factors from the beginning to the end of the study in the control group with normal diet and in experimental group 2 treated with pre-cholesterol diet at a dose of 170 mg/kg TPHAE (*P*\>0.05). Also, there was a decrease in serum HDL-c levels in both sham and experimental groups 1, compared to the beginning of the study, while the level decreased in the sham group from 33.82 mg/dL at the beginning of the study to 21.56 mg/dL at the end of the study (*P*\<0.001), and in experimental group 1 it decreased from 35.06 mg/dL at the beginning of the study to 24.50 mg/dL at the end of the study (*P*\<0.01). However, there were no significant changes in serum HDL-c levels in the control and two experimental groups compared to the beginning of the study ([Table 2](#t2-jir-11-265){ref-type="table"}).

After the intervention and at the end of the eighth week, the mean lipid profile and lipid profiles were compared between the groups ([Figures 1](#f1-jir-11-265){ref-type="fig"} and [2](#f2-jir-11-265){ref-type="fig"}); the results indicated that at the end of the eighth week, the mean lipid profile of control and experimental group 2 had a significant decrease compared to the sham group (*P*\<0.001). This decrease was also observed in experimental group 2 compared to experimental group 1 (*P*\<0.001). Also, in experimental group 1, the mean concentration of TG and cholesterol had a significant decrease compared to the sham group (*P*\<0.05 and *P*\<0.001, respectively). The mean HDL-c of the control group and experimental group 2 had a significant increase compared to the sham group (*P*\<0.001). Also, in experimental group 1, the mean concentration of cholesterol, TG and LDL-c had a significant increase, and mean HDL-c had a significant decrease compared to the control group (*P*\<0.001) ([Figure 1](#f1-jir-11-265){ref-type="fig"}).

At the end of the eighth week, the mean of inflammatory factors was significantly lower in all groups than in the sham group (*P*\<0.001). This decrease was also observed in experimental group 2 in the inflammatory indices of fibrinogen, TNF-α (*P*\<0.001) and IL-6 (*P*\<0.05) compared to experimental group 1. The level of all inflammatory indices except CRP in experimental group 1 had a significant increase compared to the control group (*P*\<0.001) ([Figure 2](#f2-jir-11-265){ref-type="fig"}).

Discussion
==========

As mentioned earlier, despite the use of multiple preventive measures cardiovascular diseases are still one of the most common causes of mortality in most societies leading to millions of mortalities annually due to complications from diseases such as heart attack, angina pectoris and heart stroke.[@b4-jir-11-265],[@b6-jir-11-265] In many studies, hyperlipidemia has been identified as an important risk factor for atherosclerosis and cardiovascular disease, and its role in the development of such diseases has been proven.[@b17-jir-11-265],[@b18-jir-11-265] Therefore, the control and treatment of hyperlipidemia can be an important step toward reducing cardiovascular disease.

From the results of this study it was found that there was a significant increase in the levels of serum TG, cholesterol and LDL-c after administration of high-cholesterol diet, while serum HDL-c levels significantly decreased. Administration of hydroalcoholic extract of *T. polium* significantly reduced serum TG, cholesterol and LDL-c levels and significantly increased serum HDL-c levels in treated rats compared with the sham group. The effects of hypolipidemia of hydroalcoholic extract of *T*.*polium* in the present study are consistent with previous studies. For example, Haraguchi et al studied the effects of aqueous extract of *T*.*polium* on serum cholesterol levels; after conducting the relevant experiments, it was concluded that the aqueous extract of *T*.*polium* can reduce total cholesterol levels in the animal model by 29--46%.[@b19-jir-11-265] The study by Rasekh et al also found the anti-lipid profile of the aqueous extract of pea petiole in rats.[@b20-jir-11-265] Researchers have also investigated the hypolipidemia effect of *T*.*polium* in diabetic animals; their studies have proven that treatment with peppermint plant significantly reduces hyperlipidemia and reduces the hypolipidemia effect of this plant, TG levels and serum cholesterol in diabetic animals. Therefore, this product can possibly prevent complications caused by dyslipidemia in diabetic patients.[@b16-jir-11-265],[@b21-jir-11-265],[@b22-jir-11-265] *T*.*polium* contains a wide range of active agents including alkaloids, glycosides, terpenoids, sterols, triterpenes and flavonoids.[@b23-jir-11-265],[@b24-jir-11-265] Some types of flavonoids may eliminate lipid synthesis and liver secretion.[@b25-jir-11-265]

On the other hand, hypolipidemic and antioxidants compounds prevent progression of atherosclerosis and result in regression of this disease.[@b26-jir-11-265] Studies have shown that prevention of the development of atherosclerosis is associated with the reduction of oxidative stress.[@b6-jir-11-265] Oxidative stress is one of the important factors in increasing the production of RONs associated with hyperlipidemia.[@b27-jir-11-265],[@b28-jir-11-265] Hyperlipidemia results in inactivation of nitric oxide and ultimately endothelial damage in all stages of atherosclerosis by increasing the production of superoxide.[@b29-jir-11-265] Cardiovascular risk factors increase the oxidation of lipids, leading to normal vascular endothelial dysfunction and the formation of plaque atheroma.[@b26-jir-11-265] During the process of lipid peroxidation, there are several steps that result in the production of a wide range of substances, including free oxygen radicals, ketones, ethers, aldehydes and foam cells. These compounds interfere with the attachment of endothelial cells and formation of plaque.[@b30-jir-11-265]

Other results of this study involved the investigation of the effect of *T*.*polium* on the levels of blood inflammatory factors. In clinical trials, it involved blood inflammatory factors including CRP, TNF-α, IL-β1 and IL-6 along with the development of cardiovascular diseases, including coronary artery sclerosis.[@b31-jir-11-265],[@b32-jir-11-265] With increasing oxidative stress, inflammation increases, which is associated with an increase in the level of inflammatory factors.[@b33-jir-11-265] Some inflammatory factors, including CRP, have been elevated with an increase in cholesterol levels and are considered as important factors in predicting cardiovascular disease.[@b34-jir-11-265] The results of this study indicate that hydroalcoholic extract of blood has the potential to reduce inflammatory factors; administration of hydroalcoholic extract of *T*.*polium* causes a significant decrease in serum levels of IL-6, CRP, fibrinogen and TNF-α. Similar to the results of this study, previous studies have reported that *T*.*polium* has antioxidant and anti-inflammatory activities.[@b14-jir-11-265],[@b35-jir-11-265] In a study investigating the anti-inflammatory activity of *T*.*polium* against edema caused by carrageenan in rats, it was shown that this herb has an anti-inflammatory effect.[@b36-jir-11-265] In another study by Radhakrishnan et al, it was concluded that topical use of *T*.*polium* extract had an anti-inflammatory effect.[@b37-jir-11-265]

Oxygen radicals play an essential role in development of atherosclerosis.[@b38-jir-11-265] Fats and proteins are damaged by free radicals, resulting in loss of integrity and pro-inflammatory cytokines.[@b39-jir-11-265]

It seems that the antioxidant effect of the hydroalcoholic extract of *T*.*polium* is due to its flavonoid and phenolic compound content. Flavonoids protect the cells against the destructive effects of reactive oxygen species such as superoxide radicals because of their antioxidant activity.[@b11-jir-11-265] Flavonoids also reduce inflammatory processes by activating several pathways.[@b40-jir-11-265] Compounds such as soluble fiber, vitamin E, flavonoids and sterols have anti-atherosclerotic effects, antioxidant and anti-inflammatory effects along with maintaining endothelial activity.[@b41-jir-11-265],[@b42-jir-11-265] Farshchi et al showed that the anti-inflammatory effects of aqueous extract of *T*.*polium* can be due to central and peripheral mechanisms, which are caused by the presence of alkaloids, flavonoids and terpenoids.[@b43-jir-11-265] In this study, doses of 85 and 170 mg/kg were used. From the results it was found that the protective effect was dose dependent, as shown in the dose of 170 mg/kg. In the study conducted by Pourmotabbed et al, anti-inflammatory effects of the aqueous extract of *T*.*polium* were reported.[@b36-jir-11-265] In a study by Khleifat et al, the effects of long-term treatment of *T*.*polium* ethanolic extract on blood and biochemical, liver and kidney histopathology parameters in rats were investigated; this study revealed some of the phytotoxic effects of *T*.*polium* on the liver and kidneys through the long-term treatment.[@b44-jir-11-265] The findings of previous studies also reported acute hepatic failure in humans after use of chronic *T*.*polium* and its similar genus (*Teucrium chamaedrys*).[@b45-jir-11-265],[@b46-jir-11-265] In this study, the toxicity test (LD~50~) was used to assess the toxicity of the drug, and the safety of the alcoholic extract of *T*.*polium* was confirmed in the applied doses. Other studies have also confirmed this result and have shown the safety of the studied extract.[@b40-jir-11-265],[@b47-jir-11-265] Therefore, it can be concluded that hydroalcoholic extract of *T*.*polium* is effective in reducing the level of inflammatory factors and lipid profiles in animal samples. However, further studies are needed in humans considering the confirmed phytotoxic effects of this plant in previous studies.

Conclusion
==========

The results of this study showed that administration of hydroalcoholic extracts of *T*.*polium* in hypercholesterolemic rats significantly decreased serum levels of TG, cholesterol and LDL-c and significantly increased serum HDL-c levels. The extract also had the potential to reduce inflammatory factors, which resulted in a significant decrease in serum levels of IL-6, CRP, fibrinogen and TNF-α in hypercholesterolemic rats. The mechanism of this plant is likely to produce hypolip-idemic and anti-inflammatory effects due to its polyphenolic compounds content. In addition, the results of the present study indicated that the protective effect of hydroalcoholic extract of *T*.*polium* was dose dependent as it was observed at a dose of 170 mg/kg. It can be concluded that a dose of 170 mg/kg of TPHAE has the potential to be a natural product to manage cardiovascular disease.
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![Effect of hydroalcoholic extracts of *Teucrium polium* on lipid profile (TG, cholesterol, LDL-c and HDL-c) in different groups.\
**Notes:** The *P*-values for the following comparisons are as follows: end level serum of control vs. sham group (a=0.000); end level serum of Exp 1 vs. sham group (TG: b=0.016, cholesterol: b=0.000, LDL-c: b=0.345, HDL-c: b=0.355); end level serum of Exp 2 vs. sham group (c=0.000); end level serum of Exp 1 vs. control group (d=0.000); end level serum of Exp 2 vs. control group (TG: e=0.773, cholesterol: e=0.982, LDL-c: e=0.967, HDL-c: e=0.622) and end level serum of Exp 2 vs. Exp 1 group (f=0.000). (The mean difference is significant at the 0.05 level).\
**Abbreviations:** TG, triglyceride; LDL-c, LDL-cholesterol; HDL-c, HDL-cholesterol; Exp, experimental.](jir-11-265Fig1){#f1-jir-11-265}

![Effect of hydroalcoholic extracts of *Teucrium polium* on inflammatory indicators (IL-6, TNF-α, CRP and fibrinogen) in different groups.\
**Notes:** The *P*-values for the following comparisons are as follows: end level serum of control vs. sham group (a=0.000); end level serum of Exp 1 vs. sham group (b=0.000); end level serum of Exp 2 vs. sham group (c=0.000); end level serum of Exp 1 vs. control group (IL-6, TNF-α and fibrinogen: d=0.000, CRP: d=0.197); end level serum of Exp 2 vs. control group (IL-6: e=0.198, TNF-α and CRP: e=1.000, fibrinogen: e=0.933) and end level serum of Exp 2 vs. exp 1 group (IL-6: f=0.016, TNF-α and fibrinogen: f=0.000, CRP: f=0.296). (The mean difference is significant at the 0.05 level.)\
**Abbreviations:** TNF-α, tumor necrosis factor-α; Exp, experimental.](jir-11-265Fig2){#f2-jir-11-265}

###### 

Comparison of the mean inflammatory factors in the studied groups before and after the intervention.

  Inflammatory factors                               Control group   Sham group     Experimental group 1   Experimental group 2
  ------------------------ ------------------------- --------------- -------------- ---------------------- ----------------------
  IL-6                     Before the intervention   2.82 ± 0.03     2.83 ± 0.03    2.84 ± 0.03            2.85 ± 0.02
  After the intervention   2.83 ± 0.02               3.85 ± 0.06     3.29 ± 0.08    3.01 ± 0.07            
  *P*-value                0.745                     0.000           0.009          0.065                  
  TNF-α                    Before the intervention   10.84 ± 0.23    10.88 ± 0.23   11.04 ± 0.22           10.90 ± 0.18
  After the intervention   11.08 ± 0.18              16.20 ± 0.19    12.66 ± 0.14   11.04 ± 0.20           
  *P*-value                0.186                     0.000           0.000          0.52                   
  CRP                      Before the intervention   1.77 ± 0.06     1.81 ± 0.06    1.72 ± 0.06            1.69 ± 0.07
  After the intervention   1.78 ± 0.06               2.98± 0.07      2.06 ± 0.08    1.81 ± 0.11            
  *P*-value                0.423                     0.000           0.038          0.082                  
  Fibrinogen               Before the intervention   2.14 ± 0.09     2.22 ± 0.06    2.16 ± 0.08            2.18 ± 0.58
  After the intervention   2.16 ± 0.05               3.92 ± 0.06     2.84 ± 0.10    2.34 ± 0.10            
  *P*-value                0.749                     0.000           0.001          0.078                  

**Notes:** Data were presented based on mean ± SD. Meaningful statistical significance was calculated using independent *t*-test.

**Abbreviation:** TNF-α, tumor necrosis factor-α.

###### 

comparison of the mean lipid profile in the studied groups before and after the intervention.

  Lipid profile                                      Control group   Sham group      Experimental group 1   Experimental group 2
  ------------------------ ------------------------- --------------- --------------- ---------------------- ----------------------
  TG                       Before the intervention   70.10 ± 2.48    68.34 ± 2.49    66.58 ± 1.85           67.64 ± 2.87
  After the intervention   71.32 ± 2.11              114.58 ± 2.90   102.06 ± 2.39   75.92 ± 2.96           
  *P*-value                0.274                     0.01            0.001           0.055                  
  Cholesterol              Before the intervention   82.32 ± 2.77    82.46 ± 2.14    81.28 ± 1.80           83.81 ± 2.00
  After the intervention   84.38 ± 2.59              141.22 ± 3.27   108.09 ± 3.97   87.18 ± 2.80           
  *P*-value                0.210                     0.001           0.01            0.367                  
  LDL-c                    Before the intervention   45.38 ± 1.59    45.60 ± 1.38    43.42 ± 1.75           48.58 ± 0.92
  After the intervention   46.30 ± 1.29              76.02 ± 2.33    70.18 ± 2.45    48.56 ± 2.10           
  *P*-value                0.257                     0.001           0.01            0.993                  
  HDL-c                    Before the intervention   34.40 ± 0.52    33.82 ± 0.58    35.06 ± 0.96           35.16 ± 0.75
  After the intervention   35.02 ± 0.88              21.56 ± 0.76    24.50 ± 1.03    32.74 ±0.96            
  *P*-value                0.321                     0.001           0.002           0.124                  

**Notes:** Data were presented based on mean ± SD. Meaningful statistical significance was calculated using independent *t*-test.

**Abbreviations:** TG, triglyceride; LDL-c, LDL-cholesterol; HDL-c, HDL-cholesterol.
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